ARROWHEAD PHARMACEUTICALS IN
ARWRNASDAQ🏆 #931 by market capEarnings Nov 23 · PostUS Equity
$66.25▲ $0.80 (+1.21%)
🌙 After hours$67.72▲ 2.22%Regular close · extended-hours price shownTrack ARWR
Get earnings, price moves & breaking news on Telegram
24h▲ 1.2%
7d▼ 1.0%
14d▲ 0.7%
30d▼ 19.6%
ytd▼ 0.2%
1y▲ 91.9%
🏦Market Cap
$9.33B
Small Cap
📈Revenue Growth (YoY)
+23258.2%
High Growth
📊Gross Margin
100.0%
High
💵FCF Margin
-11.2%
Thin
⚖️P/S Ratio
13.8x
Elevated
Otter Score
36
Weak
ARROWHEAD PHARMACEUTICALS IN
ARWRAnalyst Ratings
Price
$66.25
Total
22
Raised
3
Lowered
2
Avg PT
$100.63
H / L
$126 / $46
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-09-01 | — | — |
Chardan Capital | Reiterated | Buy | 2026-08-31 | $115.00 | +73.60% |
RBC Capital | Reiterated | Outperform | 2026-08-31 | $100.00 | +50.90% |
B. Riley Securities | Reiterated | Buy | 2026-07-30 | — | — |
Morgan Stanley | Reiterated | Overweight | 2026-07-23 | $120.00 | +81.10% |
Piper Sandler | Reiterated | Overweight | 2026-07-23 | $126.00 | +90.20% |
JP Morgan | Reiterated | Overweight | 2026-07-17 | — | — |
Leerink Partners | Reiterated | Market Perform | 2026-06-17 | $31.00 | −53.20% |
Bernstein | Reiterated | Market Perform | 2026-05-13 | $46.00 | −30.60% |
Goldman Sachs | Reiterated | Neutral | 2026-01-07 | $74.00 | +11.70% |
B of A Securities | Reiterated | Buy | 2025-12-09 | — | — |
Citigroup | Reiterated | Neutral | 2025-05-13 | $27.00 | −59.20% |
Cantor Fitzgerald | Reiterated | Overweight | 2023-08-08 | — | — |
SVB Leerink | Downgraded | Outperform → Market Perform | 2023-05-12 | — | — |
SVB Securities | Upgraded | Market Perform → Outperform | 2023-04-12 | — | — |
Baird | Reiterated | Outperform | 2023-02-07 | — | — |
Jefferies | Reiterated | Buy | 2022-11-29 | $75.00 | +13.20% |
B. Riley FBR | Reiterated | Buy | 2021-02-08 | — | — |
B. Riley | Reiterated | Buy | 2019-08-19 | — | — |
PiperJaffray | Upgraded | Neutral → Overweight | 2017-11-27 | — | — |
William Blair | Upgraded | Market Perform → Outperform | 2017-09-18 | — | — |
Deutsche Bank | Downgraded | Buy → Hold | 2015-01-22 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-09-01
—
—
Chardan Capital
Reiterated · Buy · 2026-08-31
$115.00
+73.60%
RBC Capital
Reiterated · Outperform · 2026-08-31
$100.00
+50.90%
B. Riley Securities
Reiterated · Buy · 2026-07-30
—
—
Morgan Stanley
Reiterated · Overweight · 2026-07-23
$120.00
+81.10%
Piper Sandler
Reiterated · Overweight · 2026-07-23
$126.00
+90.20%
JP Morgan
Reiterated · Overweight · 2026-07-17
—
—
Leerink Partners
Reiterated · Market Perform · 2026-06-17
$31.00
−53.20%
Bernstein
Reiterated · Market Perform · 2026-05-13
$46.00
−30.60%
Goldman Sachs
Reiterated · Neutral · 2026-01-07
$74.00
+11.70%
B of A Securities
Reiterated · Buy · 2025-12-09
—
—
Citigroup
Reiterated · Neutral · 2025-05-13
$27.00
−59.20%
Cantor Fitzgerald
Reiterated · Overweight · 2023-08-08
—
—
SVB Leerink
Downgraded · Outperform → Market Perform · 2023-05-12
—
—
SVB Securities
Upgraded · Market Perform → Outperform · 2023-04-12
—
—
Baird
Reiterated · Outperform · 2023-02-07
—
—
Jefferies
Reiterated · Buy · 2022-11-29
$75.00
+13.20%
B. Riley FBR
Reiterated · Buy · 2021-02-08
—
—
B. Riley
Reiterated · Buy · 2019-08-19
—
—
PiperJaffray
Upgraded · Neutral → Overweight · 2017-11-27
—
—
William Blair
Upgraded · Market Perform → Outperform · 2017-09-18
—
—
Deutsche Bank
Downgraded · Buy → Hold · 2015-01-22
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space